血小板减少合并缺血性卒中的诊治进展

Progress in Diagnosis and Treatment of Ischemic Stroke Patients with Thrombocytopenia

在临床中,如果免疫性血小板减少(immune thrombocytopenia,ITP)、肝素诱发的血小板减少(heparin-induced thrombocytopenia,HIT)、血栓性血小板减少性紫癜(thrombotic thrombocytopenic purpura,TTP)等血小板减少疾病患者合并缺血性卒中,其治疗存在矛盾。本文对血小板减少的病因机制及血小板减少合并急性缺血性卒中时静脉溶栓、机械取栓及抗血小板治疗等方面的研究进展进行了综述。

There are contradictions in treatment of thrombocytopenia combined with ischemic stroke,such as immune thrombocytopenia(ITP),heparin-induced thrombocytopenia(HIT)and thrombotic thrombocytopenic purpura(TTP).This article reviewed that the etiological mechanism of thrombocytopenia,and advance in intravenous thrombolysis,mechanical thrombolysis and antiplatelet therapy in patients with thrombocytopenia and ischemic stroke.